8-K//Current report
VYNE Therapeutics Inc. 8-K
Accession 0001104659-25-089531
$VYNECIK 0001566044operating
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 4:03 PM ET
Size
192.2 KB
Accession
0001104659-25-089531
Documents
- 8-Ktm2525917d1_8k.htmPrimary
FORM 8-K
- EX-101.SCHvyne-20250911.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABvyne-20250911_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREvyne-20250911_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001104659-25-089531-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLtm2525917d1_8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
VYNE Therapeutics Inc.
CIK 0001566044
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001566044
Filing Metadata
- Form type
- 8-K
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 4:03 PM ET
- Size
- 192.2 KB